{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,3]],"date-time":"2026-07-03T15:20:22Z","timestamp":1783092022400,"version":"3.54.6"},"reference-count":18,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001807","name":"State of Sao Paulo Research Foundation","doi-asserted-by":"publisher","award":["2022\/13655-4"],"award-info":[{"award-number":["2022\/13655-4"]}],"id":[{"id":"10.13039\/501100001807","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003593","name":"National Council for Scientific and Technological Development","doi-asserted-by":"publisher","award":["446140\/2024-4"],"award-info":[{"award-number":["446140\/2024-4"]}],"id":[{"id":"10.13039\/501100003593","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003593","name":"National Council for Scientific and Technological Development","doi-asserted-by":"publisher","award":["440713\/2022-6"],"award-info":[{"award-number":["440713\/2022-6"]}],"id":[{"id":"10.13039\/501100003593","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Trends in Pharmacological Sciences"],"published-print":{"date-parts":[[2026,6]]},"DOI":"10.1016\/j.tips.2026.04.010","type":"journal-article","created":{"date-parts":[[2026,5,18]],"date-time":"2026-05-18T04:29:38Z","timestamp":1779078578000},"page":"590-593","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Targeting competitive Fe\u2013S regulation to treat Friedreich\u2019s ataxia"],"prefix":"10.1016","volume":"47","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0075-7209","authenticated-orcid":false,"given":"Juliane C.","family":"Campos","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2694-239X","authenticated-orcid":false,"given":"Julio C.B.","family":"Ferreira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.tips.2026.04.010_bb0005","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1016\/S1474-4422(25)00175-9","article-title":"Friedreich\u2019s ataxia\u2014a rare multisystem disease","volume":"24","author":"Reetz","year":"2025","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.tips.2026.04.010_bb0010","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1038\/s41582-025-01065-y","article-title":"A global perspective on research advances and future challenges in Friedreich ataxia","volume":"21","author":"Indelicato","year":"2025","journal-title":"Nat. Rev. Neurol."},{"key":"10.1016\/j.tips.2026.04.010_bb0015","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1002\/ana.25934","article-title":"Safety and efficacy of omaveloxolone in Friedreich ataxia (MOXIe study)","volume":"89","author":"Lynch","year":"2021","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.tips.2026.04.010_bb0020","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1038\/s41586-025-09821-2","article-title":"Mutations in mitochondrial ferredoxin FDX2 suppress frataxin deficiency","volume":"649","author":"Meisel","year":"2026","journal-title":"Nature"},{"key":"10.1016\/j.tips.2026.04.010_bb0025","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1038\/s41586-025-09822-1","article-title":"Cross-regulation of [2Fe\u20132S] cluster synthesis by ferredoxin-2 and frataxin","volume":"649","author":"Want","year":"2026","journal-title":"Nature"},{"key":"10.1016\/j.tips.2026.04.010_bb0030","doi-asserted-by":"crossref","first-page":"3269","DOI":"10.1038\/s41467-024-47310-8","article-title":"Mechanism and structural dynamics of sulfur transfer during de novo [2Fe-2S] cluster assembly on ISCU2","volume":"15","author":"Schulz","year":"2024","journal-title":"Nat. Commun."},{"key":"10.1016\/j.tips.2026.04.010_bb0035","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-024-54585-4","article-title":"Two-stage binding of mitochondrial ferredoxin-2 to the core iron-sulfur cluster assembly complex","volume":"15","author":"Steinhilper","year":"2024","journal-title":"Nat. Commun."},{"key":"10.1016\/j.tips.2026.04.010_bb0040","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1016\/j.omtm.2022.02.002","article-title":"In vivo overexpression of frataxin causes toxicity mediated by iron-sulfur cluster deficiency","volume":"24","author":"Huichalaf","year":"2022","journal-title":"Mol. Ther. Methods Clin. Dev."},{"key":"10.1016\/j.tips.2026.04.010_bb0045","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1038\/s41392-024-02036-3","article-title":"New insights into protein\u2013protein interaction modulators in drug discovery and therapeutic advance","volume":"9","author":"Nada","year":"2024","journal-title":"Signal Transduct. Target. Ther."},{"key":"10.1016\/j.tips.2026.04.010_bb0050","doi-asserted-by":"crossref","first-page":"1923","DOI":"10.1016\/j.cell.2026.01.034","article-title":"Efficient amyloid-\u03b2 degradation in Alzheimer\u2019s disease using SPYTACs","volume":"189","author":"Teng","year":"2026","journal-title":"Cell"},{"key":"10.1016\/j.tips.2026.04.010_bb0055","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1038\/s41467-018-08276-6","article-title":"A selective inhibitor of mitofusin 1-\u03b2IIPKC association improves heart failure outcome in rats","volume":"10","author":"Ferreira","year":"2019","journal-title":"Nat. Commun."},{"key":"10.1016\/j.tips.2026.04.010_bb0060","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1038\/s44161-024-00512-1","article-title":"Cardiac troponin I directly binds and inhibits mitochondrial ATP synthase with a noncanonical role in the post-ischemic heart","volume":"3","author":"Elezaby","year":"2024","journal-title":"Nat. Cardiovasc. Res."},{"key":"10.1016\/j.tips.2026.04.010_bb0065","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.1038\/s41467-017-01497-1","article-title":"Structure and functional dynamics of the mitochondrial Fe\/S cluster synthesis complex","volume":"8","author":"Boniecki","year":"2017","journal-title":"Nat. Commun."},{"key":"10.1016\/j.tips.2026.04.010_bb0070","doi-asserted-by":"crossref","first-page":"6501","DOI":"10.1016\/j.cell.2024.10.038","article-title":"Discovery and significance of protein-protein interactions in health and disease","volume":"187","author":"Greenblatt","year":"2024","journal-title":"Cell"},{"key":"10.1016\/j.tips.2026.04.010_bb0075","doi-asserted-by":"crossref","DOI":"10.1002\/pro.5197","article-title":"Unraveling the molecular determinants of a rare human mitochondrial disorder caused by the P144L mutation of FDX2","volume":"33","author":"Grifagni","year":"2024","journal-title":"Protein Sci."},{"key":"10.1016\/j.tips.2026.04.010_bb0080","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1038\/s41419-023-06320-y","article-title":"Human frataxin, the Friedreich ataxia deficient protein, interacts with mitochondrial respiratory chain","volume":"14","author":"Doni","year":"2023","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.tips.2026.04.010_bb0085","doi-asserted-by":"crossref","first-page":"1507","DOI":"10.1016\/j.cell.2019.03.045","article-title":"Hypoxia rescues frataxin loss by restoring iron sulfur cluster biogenesis","volume":"177","author":"Ast","year":"2019","journal-title":"Cell"},{"key":"10.1016\/j.tips.2026.04.010_bb0090","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1038\/s41419-025-08323-3","article-title":"A novel mutation in FDX2 provides insights into the pathogenesis of MEOAL mitochondrial neuromuscular disease","volume":"17","author":"Doni","year":"2025","journal-title":"Cell Death Dis."}],"container-title":["Trends in Pharmacological Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165614726001082?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165614726001082?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,3]],"date-time":"2026-07-03T14:57:12Z","timestamp":1783090632000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0165614726001082"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6]]},"references-count":18,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2026,6]]}},"alternative-id":["S0165614726001082"],"URL":"https:\/\/doi.org\/10.1016\/j.tips.2026.04.010","relation":{},"ISSN":["0165-6147"],"issn-type":[{"value":"0165-6147","type":"print"}],"subject":[],"published":{"date-parts":[[2026,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Targeting competitive Fe\u2013S regulation to treat Friedreich\u2019s ataxia","name":"articletitle","label":"Article Title"},{"value":"Trends in Pharmacological Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.tips.2026.04.010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}